On September 28, 2018 Stemline Therapeutics, Inc. (Nasdaq: STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, reported that Ivan Bergstein, M.D., Stemline’s CEO, is scheduled to present at two upcoming investor conferences (Press release, Stemline Therapeutics, SEP 28, 2018, View Source [SID1234529646]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Cantor Global Healthcare Conference on Monday, October 1, 2018 at 4:40 PM ET, being held at the InterContinental New York Barclay Hotel in New York City.
The Ladenburg Thalmann 2018 Healthcare Conference on Tuesday, October 2, 2018 at 2:00 PM ET, being held at the Sofitel New York in New York City.
A webcast of both presentations can be viewed on the company’s website at www.stemline.com.